Over the last 7 days, the Biotech industry has dropped 8.0%, driven by Idorsia declining 11%. This takes the industry's 12 month performance to a gain of 3.9%. Earnings are forecast to grow by 16% annually.
Has the Swiss Biotech Industry valuation changed over the past few years?
Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
---|---|---|---|---|---|---|
Fri, 26 Apr 2024 | CHF394.2m | CHF67.2m | -CHF172,318,778.62 | 0.1x | -2.3x | 5.9x |
Sun, 24 Mar 2024 | CHF340.9m | CHF67.3m | -CHF173,226,506.34 | 0.2x | -2x | 5.1x |
Tue, 20 Feb 2024 | CHF400.8m | CHF55.5m | -CHF173,220,198.62 | 1x | -2.3x | 7.2x |
Thu, 18 Jan 2024 | CHF344.4m | CHF317.7m | -CHF175,983,810.00 | 0.6x | -2x | 1.1x |
Sat, 16 Dec 2023 | CHF298.2m | CHF317.8m | -CHF208,848,298.00 | n/a | -1.4x | 0.9x |
Mon, 13 Nov 2023 | CHF292.3m | CHF318.5m | -CHF211,286,620.00 | n/a | -1.4x | 0.9x |
Wed, 11 Oct 2023 | CHF251.6m | CHF318.4m | -CHF213,238,640.00 | n/a | -1.2x | 0.8x |
Fri, 08 Sep 2023 | CHF298.1m | CHF318.6m | -CHF188,945,875.00 | n/a | -1.6x | 0.9x |
Sun, 06 Aug 2023 | CHF528.8m | CHF323.7m | -CHF180,059,754.00 | n/a | -2.9x | 1.6x |
Tue, 04 Jul 2023 | CHF308.8m | CHF330.8m | -CHF180,800,170.00 | n/a | -1.7x | 0.9x |
Thu, 01 Jun 2023 | CHF312.0m | CHF334.0m | -CHF183,619,507.00 | n/a | -1.7x | 0.9x |
Sat, 29 Apr 2023 | CHF365.2m | CHF498.8m | -CHF18,436,101.00 | 1.6x | -19.8x | 0.7x |
Mon, 27 Mar 2023 | CHF426.5m | CHF497.1m | CHF11.5m | 1.5x | 37x | 0.9x |
Wed, 22 Feb 2023 | CHF474.3m | CHF493.4m | CHF14.5m | 1.6x | 32.7x | 1x |
Fri, 20 Jan 2023 | CHF521.2m | CHF493.4m | CHF14.5m | 1.8x | 35.9x | 1.1x |
Sun, 18 Dec 2022 | CHF500.1m | CHF493.4m | CHF14.5m | 1.7x | 34.5x | 1x |
Tue, 15 Nov 2022 | CHF537.5m | CHF493.2m | CHF15.0m | 1.8x | 35.8x | 1.1x |
Thu, 13 Oct 2022 | CHF515.9m | CHF510.2m | CHF15.9m | 1.9x | 32.5x | 1x |
Sat, 10 Sep 2022 | CHF517.7m | CHF496.2m | CHF27.8m | 1.8x | 18.6x | 1x |
Mon, 08 Aug 2022 | CHF534.3m | CHF487.8m | CHF42.2m | 2x | 12.6x | 1.1x |
Wed, 06 Jul 2022 | CHF537.3m | CHF457.9m | CHF81.3m | 2.1x | 6.6x | 1.2x |
Fri, 03 Jun 2022 | CHF649.0m | CHF468.5m | CHF24.7m | 2.1x | 26.2x | 1.4x |
Sun, 01 May 2022 | CHF725.5m | CHF299.6m | -CHF141,437,692.00 | 1.9x | -5.1x | 2.4x |
Tue, 29 Mar 2022 | CHF1.2b | CHF286.0m | -CHF138,938,782.00 | 2x | -8.8x | 4.3x |
Thu, 24 Feb 2022 | CHF1.3b | CHF281.6m | -CHF139,054,314.00 | 2x | -9.2x | 4.5x |
Sat, 22 Jan 2022 | CHF5.3b | CHF315.6m | -CHF659,277,194.00 | 1.5x | -8x | 16.8x |
Mon, 20 Dec 2021 | CHF4.1b | CHF318.2m | -CHF658,912,125.00 | 1.5x | -6.2x | 12.9x |
Wed, 17 Nov 2021 | CHF4.0b | CHF318.0m | -CHF658,936,363.00 | 1.5x | -6.1x | 12.7x |
Fri, 15 Oct 2021 | CHF4.7b | CHF294.2m | -CHF585,251,048.00 | 2.3x | -8x | 15.9x |
Sun, 12 Sep 2021 | CHF5.1b | CHF305.7m | -CHF612,309,374.80 | 1.3x | -8.4x | 16.8x |
Tue, 10 Aug 2021 | CHF5.5b | CHF306.0m | -CHF612,309,374.80 | 1.1x | -8.9x | 17.8x |
Mon, 03 May 2021 | CHF5.5b | CHF352.3m | -CHF535,605,963.80 | 1.1x | -10.4x | 15.7x |
-10.4x
How does Swiss Biotech compare with similar industries?
CH Market | 0.027% | |
Healthcare | 2.22% | |
Biotech | -7.96% | |
Biotech | -7.96% |
Which companies have driven the market over the last 7 days?
Company | Last Price | 7D | 1Y | Valuation | |
---|---|---|---|---|---|
SANN Santhera Pharmaceuticals Holding | CHF9.50 | 1.4% +CHF1.2m | 50.8% | PS1.6x | |
SPEX Spexis | CHF0.059 | 14.0% +CHF487.2k | -85.0% | PS3.4x | |
OBSN ObsEva | CHF0.006 | 20.0% +CHF117.2k | -93.2% | PE0.1x |